Evaluation of AdvanCore Bone Graft for Bone Healing
Official title: Study on Safety and Performance of AdvanCore Bone Void Filler
Run by Artur Salgado SA · NCT06736457 · Data updated 2026-11-12
This study is testing if the AdvanCore bone graft can help adults with serious bone defects heal better over a year.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 190 (estimated) |
| Sponsor | Artur Salgado SA Industry-sponsored |
| Locations | 4 sites (Guimarães, Braga District and 3 other locations) |
| Status | Recruiting |
| Started | May 29, 2025 |
| Main results expected | October 2026 |
| Study ends | October 2026 |
| Registry record updated | May 31, 2025 |
| Trial ID | NCT06736457 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who require a bone grafting procedure for non-healing bone lesions.
✕Probably not a fit
Patients with infections at the graft site or those who are hypersensitive to any components of AdvanCore may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and performance of the AdvanCore bone graft, a porous beta-tricalcium phosphate device, over a 12-month follow-up period. It is designed for adult patients with bone defects that exceed the body's natural healing capabilities, and it will be conducted in a multi-center, open-label format across various European sites. Participants will receive the AdvanCore graft, which acts as a temporary scaffold to aid in bone regeneration, and will be monitored for outcomes related to safety and effectiveness.
Why it matters
Potential benefit: If successful, this study could improve bone healing outcomes for patients with significant bone defects.
How similar studies have gone: Other studies involving beta-tricalcium phosphate bone grafts have shown promising results, indicating that this approach is supported by prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult subjects ≥ 18 years old, male or female. * Subjects who are eligible for a bone grafting/bone void filler procedure. * Subjects with bone lesions beyond the limits of the bone's self-healing ability. * Subjects, and/or an authorized representative, who are willing and capable of providing informed consent, participating in all testing associated with this clinical investigation at an approved clinical investigational center. * Subjects with only one fracture susceptible to treatment with an AdvanCore implant. Exclusion Criteria: * Subjects with any AdvanCore contraindication for implantation or use. * Subjects with hypersensitivity to any of the AdvanCore components. * Subjects with infections or soft/granulation tissue in the area to place bone graft. * Subjects who are currently enrolled in another investigational study or registry that would directly interfere with the current study. * Women who are breastfeeding or of childbearing potential who are, or plan to become, pregnant during the time of the study (method of assessment upon physician's discretion).
Where it's running
-
Unidade Local de Saúde do Alto Ave
Guimarães, Braga District, Portugal Recruiting -
Unidade Local de Saúde de Trás-os-Montes e Alto Douro
Lordelo, Vila Real District, Portugal Recruiting -
Unidade Local de Saúde de São João
Porto, Porto District, Portugal Not yet recruiting -
Unidade Local de Saúde do Médio Tejo
Tomar, Santarém District, Portugal Not yet recruiting
Study contacts
- Study coordinator: Francisca C Costa
- Email: f.costa@artursalgado.pt
- Phone: +351253794649
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two bone graft materials with enamel matrix derivative to regenerate one- and two-wall periodontal bone defects
This trial will test whether adding either a bovine-derived bone graft (BioOss Collagen) or a resorbable hydroxyapatite–collagen sponge (Ossix Bone) to enamel matrix derivative helps adults with one- or two-wall intrabony periodontal defects reduce pocket depth over 12 months.
-
Iliac crest marrow versus proximal tibia Avitus bone graft for foot and ankle procedures
This will test whether bone graft taken from the proximal tibia with the Avitus device works as well as iliac crest bone marrow for adults needing autograft during foot or ankle fusion or nonunion surgery.
-
All-on-6 upper jaw implants placed with stackable guided surgery and immediate loading
This study will test whether a fully digital stackable guided surgery workflow with immediate loading works well for adults needing full-arch upper jaw (All-on-6) implants.
-
Guided Equator overdentures for the lower jaw
This project tests whether fully guided computer-assisted implant placement with Equator attachments gives reliable implant survival and less bone loss for adults with a completely edentulous lower jaw.
-
How three prosthetic methods affect bone levels around dental implants
This trial will test whether three different prosthetic approaches for posterior dental implants change marginal bone levels around the implant over one year in adults eligible for Lance implants.
-
Mandibular overdentures held by four Locator attachments versus a four-implant bar
This study tests whether mandibular overdentures retained by four Locator attachments or by a four-implant bar better preserve jaw bone in people who have been fully toothless for at least a year.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.